Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

Clinical trial NCT04633239 · RECRUITING

Trial details

NCT number: NCT04633239
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Ovarian High Grade Serous Adenocarcinoma Recurrent Platinum-Resistant Ovarian Carcinoma

Start date: 2021-07-02
Primary completion: 2026-11-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.